Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1480067
European Journal of Endocrinology, Vol 148, Issue 1, 67-72
Copyright © 2003 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hogervorst, E
Right arrow Articles by David Smith, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hogervorst, E
Right arrow Articles by David Smith, A
Articles

Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method

E Hogervorst, J Williams, M Combrinck, and A David Smith

Oxford Project To Investigate Memory and Ageing, University Department of Pharmacology, Oxford, UK. eva.hogervorst@pharm.ox.ac.uk

OBJECTIVE: Oestrogens could be protective against the development of Alzheimer's disease (AD) but reports on oestrogen levels in AD have been conflicting. DESIGN AND METHODS: A meta-analysis using robust regression was carried out to assess whether the sensitivity of the assays of past studies had affected the reported level of total oestradiol. We had also measured total oestradiol in women with AD (n=66) and controls (n=62) not using hormone replacement therapy. We used two assays for total oestradiol to assess the difference between sensitive (radioimmunoassay with a specific rabbit antibody: 3 pmol/l) and relatively insensitive (immunoassay: 37 pmol/l) assays. RESULTS: Meta-analysis using robust regression indicated that insensitive assays gave higher levels of total oestradiol when many samples fall below the level of sensitivity of the method. Earlier reports of low levels of total oestradiol in AD might be explained by this phenomenon, since total oestradiol levels (using the sensitive assay) in our controls were one third of those reported in the earlier studies. Using the sensitive assay we found that women with AD had significantly (P<0.01) higher levels (26+/-13 pmol/l) of total oestradiol than controls (21+/-13 pmol/l). Using the insensitive assay, there was no significant difference in the levels of total oestradiol. CONCLUSIONS: The sensitivity of the assay determines the reported value of the oestradiol levels. Studies using a sensitive assay do not report significantly lower levels of total oestradiol in women with AD. This weighs against the hypothesis that low levels of total oestradiol are a risk factor for AD.


This article has been cited by other articles:


Home page
 Clin Med ResHome page
K. M. Webber, G. Perry, M. A. Smith, and G. Casadesus
The Contribution of Luteinizing Hormone to Alzheimer Disease Pathogenesis
Clin. Med. Res., October 1, 2007; 5(3): 177 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. Ravaglia, P. Forti, F. Maioli, L. Bastagli, F. Montesi, N. Pisacane, M. Chiappelli, F. Licastro, and C. Patterson
Endogenous Sex Hormones as Risk Factors for Dementia in Elderly Men and Women
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2007; 62(9): 1035 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. E. Nelson, S. K. Grebe, D. J. O'Kane, and R. J. Singh
Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of Estradiol and Estrone in Human Plasma
Clin. Chem., February 1, 2004; 50(2): 373 - 384.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 European Society of Endocrinology.